Trial Profile
Peginterferon alfa-2a + ribavirin +/- fluvastatin in chronic hepatitis C patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Fluvastatin (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 May 2011 New trial record